J. Wedzicha (London, United Kingdom), R. Rodriguez-Roisin (Barcelona, Spain)
Baseline characteristics of COPD patients with frequent COPD exacerbations in tiotropium trials
D. Halpin, K. Viel, I. Leimer, L. Grönke (Exeter, United Kingdom; Ingelheim, Germany; Ridgefield, United States Of America)
|  |
Under reporting acute exacerbation in patient with COPD: incidence and predictors?
L. Langsetmo, R. Platt, P. Ernst, J. Bourbeau (Montreal, Canada)
| |
Factors effecting excacerbation rates in patients with COPD
N. A. Halis, T. Demir, N. Yildirim, S. Umut (Istanbul, Turkey)
| |
COPD exacerbations, colds and persistently high airway inflammation after 7 days
W. Perera, J. Hurst, T. Wilkinson, G. Donaldson, J. Wedzicha (London, United Kingdom)
| |
The impact of frequent exacerbations on air-trapping, dyspnea, exercise capacity and quality of life in stable COPD
S. Atis, E. S. Ozgur, M. Tumkaya, C. Ozge, S. Eker, M. Nass Duce (Mersin, Turkey)
| |
Acute exacerbations of COPD (AECOPD) in the emergency department (ED): hospitalization criteria versus predictors of death
N. Roche, D. Soussan, M. Zureik, D. Perrotin, F. Neukirch, and investigators for the ²Urgence BPCO 2003² Scientific Committee (Paris, France)
| |
Pilot study to assess short-term effect of influenza vaccination on exacerbations of COPD
S. Ting, G. South, S. W. Crookes (Chesterfield, United Kingdom)
| |
Inappropriate fractional inspired oxygen concentration (FiO2) in pre-hospital and A&E management of acute exacerbations of COPD
E. F. Hayes, U. Quinn, K. Russell, D. R. Curran, N. G. McElvaney, S. O‘Neill (Dublin, Ireland)
| |
Relationships between stable state inflammation and time to exacerbation in patients with COPD
T. M. Wilkinson, D. J. Powrie, W. R. Perera, J. R. Hurst, G. C. Donaldson, J. A. Wedzicha (London, United Kingdom)
| |
Serum C-reactive protein 14 days after a COPD exacerbation and time to the next exacerbation
W. Perera, J. Hurst, T. Wilkinson, G. Donaldson, J. Wedzicha (London, United Kingdom)
| |
Mortality predictive variables in the short-term before a COPD exacerbation
A. de Diego Damiá, M. Leon Fabregas, M. Palop Cervera, L. Compte Torrero, F. J. Bravo Gutierrez, M. Martinez Francés (Valencia, Spain)
| |
Predictors of exacerbations requiring hospitalisation in patients with stable COPD
C. Santiveri, M. Espinalt, A. Roger, R. Calvet, J. L. Marín (Barcelona, Spain)
| |
A questionnaire survey of COPD patients with readmissions and prolonged length of stay
R. Pradeep, M. Bhattacharya (Milton Keynes, United Kingdom)
| |
Risk factors for hospitalization of an acute exacerbation of COPD patients
D. Makris, P. Korakas, D. Papadopoulos, A. Damianaki, N. M. Siafakas, N. Tzanakis (Heraklion, Chania, Greece)
| |
Is venous thromboembolism (VTE) a high risk factor in patients with acute exacerbation of CPOD (AECOPD)?
O. M. ElShenawy, S. S. Salama, R. T. Ibrahim, E. M. Abd El-Sameaa, A. A. Mohamed (Assiut, Egypt)
| |
One year experience with acute COPD assessment service (ACAS) for patients with acute exacerbations of COPD
N. Diar Bakerly, C. L. Davies, S. Townsend, R. Andrews, D. P. Dhillon (Coventry, United Kingdom)
| |
Further insights from a locally developed supported discharge scheme for acute exacerbations of chronic obstructive pulmonary disease (COPD)
J. Grayez, S. George, E. Davies, J. Wilson, M. Whiting, K. Srinivasan, H. Moudgil (Telford, United Kingdom)
| |
Prophylactic efficacy of pneumococcal vaccination for chronic obstructive pulmonary disease (COPD)
I. Y. Tseimakh, T. I. Martynenko, O. S. Paraeva (Barnaul, Russian Federation)
| |
Venous thromboembolism in COPD exacerbation
I. Gulmez, H. M. Demirbas, H. Buyukoglan, S. F. Oymak, R. Demir (Kayseri, Turkey)
| |
Cardiovascular failure versus infectious disease as causes of exacerbation of COPD in a respiratory ICU
J. Vizcaino, P. Azevedo, F. Monteiro, G. Brum, J. Monteiro, R. Soto-Mayor, A. Bugalho de Almeida (Lisbon, Portugal)
| |